ArticleJournal of endocrinological investigation2025

miR-18a-3p modulates the progression of polycystic ovary syndrome by targeting CITED2 and PI3K/AKT signaling pathway.

Suping Yan et al.PubMed ↗Publisher ↗

No numbers read from the abstract.